68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

Volume: 16, Issue: 1
Published: Jun 8, 2016
Abstract
Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging of primary prostate cancer and restaging after biochemical recurrence with 68Ga-PSMA ligand Positron emission tomography/computed tomography (PET/CT). However, prospective trials and clinical guidelines for this new technique are still...
Paper Details
Title
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Published Date
Jun 8, 2016
Volume
16
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.